Tag: drug

0 0 0 Comment
Posted in HEADLINES

Biogen shares fall on report FDA head seeking investigation of her agency’s approval of Alzheimer’s drug

Biogen Inc. shares BIIB, -2.95% slid 3% Friday, after a STAT report that the acting head of the U.S. Food…

0 0 0 Comment
Posted in HEADLINES

Jazz’s leukemia drug gets approved by the FDA

Shares of Jazz Pharmaceuticals plc JAZZ, +0.18% gained 3.5% in premarket trading on Thursday, the day after the Food and…

0 0 0 Comment
Posted in HEADLINES

Seres inks deal for C. diff drug with Nestlé

Shares of Seres Therapeutics Inc. MCRB, -6.33% were down 4.9% in trading on Friday, the day after the company said…

0 0 0 Comment
Posted in HEADLINES

Amgen gets FDA approval for new lung-cancer drug

Shares of Amgen AMGN, +1.12% were up 0.5% in trading on Friday after the Food and Drug Administration said it…

0 0 0 Comment
Posted in HEADLINES

FDA advisory committee votes 10-8 in favor of ChemoCentryx’s experimental drug; stock is down

Shares of ChemoCentryx Inc. CCXI, -61.95% tumbled 61.7% in trading on Friday, the day after a Food and Drug Administration…

0 0 0 Comment
Posted in HEADLINES

AstraZeneca to withdraw drug used to treat bladder cancer

Shares of AstraZeneca AZN, -0.08% were down 0.1% in trading on Monday after the drugmaker said it voluntarily withdrew an…

0 0 0 Comment
Posted in HEADLINES

Vaccinex’s stock soars toward record gain on record volume after deals with ‘prominent’ drug makers

Shares of Vaccinex Inc. VCNX, +70.03% soared toward a record rally on record volume Friday, after the biotechnology company announced…

0 0 0 Comment
Posted in HEADLINES

Alexion Pharma pauses further enrollment in COVID-19 drug study

Alexion Pharmaceuticals Inc. ALXN, +0.55% said late Wednesday it stopped enrolling patients in a clinical study testing a treatment for…

0 0 0 Comment
Posted in HEADLINES

UPDATE: Myovant shares soar 20% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion

Shares of Myovant Sciences MYOV, -1.09% soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant will…

0 0 0 Comment
Posted in HEADLINES

Biogen Alzheimer’s drug appears to have setback as FDA advisers recommend not to approve

Biogen Inc. BIIB, -7.51% appears to have suffered a setback on Friday at the hands of a Food and Drug…

0 0 0 Comment
Posted in HEADLINES

Vertex stock falls after protein-deficiency drug development stopped

Vertex Pharmaceuticals Inc. VRTX, -1.67% stock fell in the extended session Wednesday after the biotech company said it would stop…

0 0 0 Comment
Posted in HEADLINES

Regeneron gets FDA approval for Ebola drug

Regeneron Pharmaceuticals Inc. REGN, -1.17% said late Wednesday the Food and Drug Administration approved its treatment for the Ebola virus….